In 2015, Pionyr Immunotherapeutics embarked on a journey to forge a new path in immuno-oncology for patients in need. We are a clinical stage company discovering and developing novel antibody therapeutics that dramatically alter the tumor microenvironment (TME) and enhance the body’s immune defense against cancer – with the potential to eliminate it. Pionyr's Myeloid Tuning™ cutting-edge technology is based on the discovery that “tuning” the tumor microenvironment to favor immune-activating cells and disable immune-suppressing cells improves the body’s ability to combat cancer, particularly in combination with checkpoint inhibitors. Additionally, Pionyr is building a pipeline of transmembrane and intracellular targets using our cutting-edge technologies and translational assays. Immuno-oncology is a complex field, which is why Pionyr has recruited a bold and growing team with extensive experience in immunology, immuno-oncology, target discovery, and immunotherapy development. Our “Pionyrs” are banded together by innovation, integrity, team empowerment, respect and one unified voice to translate meaningful science into promising opportunities for treating cancer.
View Top Employees from Pionyr ImmunotherapeuticsWebsite | http://www.pionyrtx.com/ |
Revenue | $6 million |
Employees | 56 (56 on RocketReach) |
Founded | 2015 |
Address | 2 Tower Pl Suite 800, South San Francisco, California 94080, US |
Phone | (650) 825-6140 |
Technologies |
JavaScript,
HTML,
Google Analytics
+12 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services |
Competitors | Abzyme Therapeutics, Teneobio, Inc., TetraGenetics Inc., Zumutor Biologics Inc., exonbio |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Pionyr Immunotherapeutics employee's phone or email?
The Pionyr Immunotherapeutics annual revenue was $6 million in 2024.
Monte Montgomery is the CFO of Pionyr Immunotherapeutics.
56 people are employed at Pionyr Immunotherapeutics.
Pionyr Immunotherapeutics is based in South San Francisco, California.
The NAICS codes for Pionyr Immunotherapeutics are [541714, 541, 54171, 54, 5417].
The SIC codes for Pionyr Immunotherapeutics are [873, 87].